INVESTOR AB - Q2 2013 holdings

$848 Million is the total value of INVESTOR AB's 13 reported holdings in Q2 2013. The portfolio turnover from Q1 2013 to Q2 2013 was - .

 Value Shares↓ Weighting
No holdings reported for quarter Q2 2013
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2013-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NASDAQ OMX GROUP INC42Q3 2023100.0%
AGILE THERAPEUTICS INC32Q1 20223.5%
CHINACACHE INTL HLDG LTD21Q2 20187.3%
MATTERSIGHT CORP21Q2 20182.0%
CORCEPT THERAPEUTICS INC18Q3 20171.8%
TANGOE INC16Q1 20174.0%
NEURONETICS INC11Q4 20203.3%
CONSTANT CONTACT INC11Q4 20150.7%
CARLYLE GROUP LP11Q1 20180.2%
STANLEY BLACK & DECKER, INC.9Q3 20230.0%

View INVESTOR AB's complete holdings history.

Latest significant ownerships (13-D/G)
INVESTOR AB Q2 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ABB LTDJune 27, 2022265,385,14214.0%
ChinaCache International Holdings Ltd.Sold outFebruary 14, 201900.0%
AGILE THERAPEUTICS INCFebruary 17, 20153,510,18918.9%
GREENWAY MEDICAL TECHNOLOGIES INCSold outFebruary 14, 201400.0%
TANGOE INCFebruary 14, 20141,440,0003.8%
Mattersight CorpSold outMay 10, 201200.0%
ISTA PHARMACEUTICALS INCFebruary 14, 20111,258,0753.8%
ACHILLION PHARMACEUTICALS INCFebruary 11, 20111,980,1293.4%
ChinaCache International Holdings Ltd.February 11, 201155,885,47514.5%
ISTA PHARMACEUTICALS INCApril 08, 20052,001,8967.8%

View INVESTOR AB's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
SC 13D/A2023-11-06
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
SC 13D/A2022-12-16
13F-HR2022-11-14
SC 13D/A2022-08-26

View INVESTOR AB's complete filings history.

Compare quarters

Export INVESTOR AB's holdings